NCT03077360View on ClinicalTrials.gov

Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

November 19, 2020

Study Completion Date

November 19, 2020

Conditions
Diabetes Mellitus, Type 2Pre-diabetesObesity
Interventions
BEHAVIORAL

Lifestyle

Lifestyle changes to lose weight or become more fit

Trial Locations (1)

80045

University of Colorado, Aurora

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Colorado, Denver

OTHER

NCT03077360 - Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans | Biotech Hunter | Biotech Hunter